Concepedia

Hans Ulrich Naegeli

HU

Statistics

Publications

4

Citations

280

H-Index

4

Active since

1986

Affiliations

Novartis (Switzerland)(Current)

Hans Ulrich Naegeli is an author at Novartis (Switzerland) specializing in chemical biology, drug resistance, and drug discovery.

Top concepts

Publications per year

1986–2009

4

Publications

4

Ribosomally Synthesized Thiopeptide Antibiotics Targeting Elongation Factor Tu

Rowan P. Morris, Jennifer A. Leeds, Hans Ulrich Naegeli et al. · Journal of the American Chemical Society · 2009 · 168 citations

, , +14

The 3D‐structure of a natural inhibitor of cell adhesion molecule expression

Ulrich Hommel, Hans‐Peter Weber, Lukas Oberer et al. · FEBS Letters · 1996 · 47 citations · Full text

Pharmacological Modulation of Endothelial Cell‐associated Adhesion Molecule Expression: Implications for Future Treatment of Dermatological Diseases

Carolyn A. Foster, Michael Dreyfuss, B. Mandak et al. · The Journal of Dermatology · 1994 · 45 citations

Clavamycins, new clavam antibiotics from two variants of Streptomyces hygroscopicus. II. Isolation and structures of clavamycins A, B and C from Streptomyces hygroscopicus NRRL 15846, and of clavamycins D, E and F from Streptomyces hygroscopicus NRRL 15879.

Hans Ulrich Naegeli, Hans‐Rudolf Loosli, Alex Nussbaumer · The Journal of Antibiotics · 1986 · 20 citations · Full text

1–4 of 4